YD BioYDES
13F holders, Q1 2026 (March 31)8holders −2
0new positions
2sold out
1famous investor
$7.70avg. 13F price*
At the end of Q1 2026, 8 institutions reported holding YD Bio Ltd. (YDES) in their 13F filings, down 2 from Q4 2025. 0 opened new positions and 2 sold out. The largest holders were Geode Capital Management, LLC ($464K), Cerity Partners LLC ($250K) and Cypress Capital Management LLC (WY) ($236K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- YD Bio Ltd.
- CUSIP
- G98301107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $21K |
All 13F filers, Q4 2025 → Q1 2026: 19,730 shares bought and 1,790 shares sold, net +17,940 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Geode Capital Management, LLC | 0.00% | Add +3.2% | 60,236 | $464K |
| Cerity Partners LLC | 0.00% | No change | 32,406 | $250K |
| Cypress Capital Management LLC (WY) | 0.22% | Add +11.4% | 30,690 | $236K |
| Citadel Advisors | 0.00% | Add +68.4% | 19,450 | $150K |
| UBS Group AG | 0.00% | Add +61.7% | 11,628 | $90K |
| Wolverine Asset Management LLC | 0.00% | Add +94.2% | 4,886 | $38K |
| Morgan Stanley | 0.00% | Reduce -25.4% | 223 | $2K |
| FMR LLC | 0.00% | No change | 1 | $8 |
"% of holder's portfolio" is YDES's weight in each manager's 13F, not the share of YD Bio Ltd. the manager owns.